The bigger test now is less about shareholder approval, which looks likely given Vereniging Aegon’s locked-in support, and more about execution risk over the roughly 18-month runway to the targeted 2028 effective date, spanning a full transition to US GAAP reporting, a new governance framework, and the operational complexity of formally becoming an American company while still carrying meaningful international operations in markets including Brazil and Bermuda-based Transamerica Life.
